LCN2 and inflammatory bowel disease: Alternatively, S100A12 (calgranulin) and lipocalin-2 in serum and feces may also emerge as biomarkers for the diagnosis of a severely inflamed digestive tract in IBD (also termed ‘active’ IBD) [16].